Pfizer: Vaccine Efficacy Declines ~6% Every Two Months
According to Pfizer’s own report titled “Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine”, their vaccine “continued to be safe and well tolerated”. Well of course it is.
But the most interesting aspect is about its vaccine efficacy (VE):
During the interval from the approximate start of observed protection at 11 days post-dose 1 to before dose 2, VE increased to 91.7% (95% CI 79.6-97.4).
From its peak post-dose 2, observed VE declined. From 7 days to <2 months post-dose 2, VE was 96.2% (95% CI [93.3-98.1]); from 2 months to <4 months, VE was 90.1% (95% CI [86.6-92.9]); and from 4 months to the data cut-off, VE was 83.7% (95% CI [74.7-89.9]).
In other words:
Efficacy peaked at 96.2% during the interval from 7 days to <2 months post-dose 2, and declined gradually to 83.7% from 4 months post-dose 2 to the data cut-off, an average decline of ~6% every 2 months.
No doubt everyone is different and it is uncertain if the decline will continue linearly, but what’s the point of a so-called vaccine if its efficacy declines approximately 6% every two months?
Be sure to subscribe to our mailing list so you get each new Opinyun that comes out!
Follow us on Farcebook, Twitterpated, Instasham, MeWe, Gab, and BooTube, as well as Parler!